Harnessing early enzymatic biomarkers and cytokines for risk prediction in post-endoscopic retrograde cholangiopancreatography pancreatitis

doi:10.3748/wjg.v31.i48.114786

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 48

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=44

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=25

Publishing Process of This Article

Item

Count

Browse

Download

Sum=4

Dec 28, 2025 (publication date) through Dec 27, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Dec 28, 2025; 31(48): 114786
Published online Dec 28, 2025. doi: 10.3748/wjg.v31.i48.114786

Open in New Tab Full Size Figure Download Figure

Figure 1 Timeline of enzymatic and cytokine biomarker peak levels after endoscopic retrograde cholangiopancreatography. ¹Clinical utility is limited by short half-life and assay variability. ²Not yet validated for clinical use. ULN: Upper limit of normal; ERCP: Endoscopic retrograde cholangiopancreatography; IL: Interleukin; TNF-α: Tumor necrosis factor-alpha; CRP: C-reactive protein; PCT: Procalcitonin.

Citation: Bouayad A. Harnessing early enzymatic biomarkers and cytokines for risk prediction in post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastroenterol 2025; 31(48): 114786
URL: https://www.wjgnet.com/1007-9327/full/v31/i48/114786.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i48.114786